Stay updated on SL-401 Combo in AML/MDS/BPDCN Clinical Trial
Sign up to get notified when there's something new on the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page.

Latest updates to the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange Detected- Added the term CD4+/CD56+ hematodermic neoplasm to the study's keywords/MeSH terms.SummaryDifference0.0%

- Check16 days agoChange DetectedRevision metadata updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a backend/UI framework update with no changes to study content or user interactions.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.4.1 is listed on the page. The previous Revision: v3.4.0 has been removed.SummaryDifference0.0%

Stay in the know with updates to SL-401 Combo in AML/MDS/BPDCN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page.